Skip to content
Search

Latest Stories

NHS and i.AI forge historic collaboration to boost healthcare

NHS and i.AI forge historic collaboration to boost healthcare
AI assisting NHS to half treatment times for stroke patients and overall patient care experience

The Department of Health and Social Care (DHSC) made a recent announcement that the Incubator for Artificial Intelligence (i.AI) and NHS England (NHSE) have joined forces in a groundbreaking move by signing a Collaboration Charter on AI.

This pivotal partnership aims to equip the NHS workforce with the tools and resources to leverage AI technology for enhancing patient care, improving staff experience, and driving operational efficiency.


The Charter, endorsed by Minister Burghart, Parliamentary Secretary for the Cabinet Office, and Lord Markham, Parliamentary Under Secretary of State at the DHSC, signifies an important step towards integrating AI into the fabric of the NHS.

Under this collaboration, the i.AI team, comprising elite technical experts within the government, will identify opportunities where AI technology can be deployed responsibly to support the NHS.

This initiative is expected to streamline processes, optimize resource allocation, and ultimately enhance patient outcomes.

Speaking on the occasion, Parliamentary Secretary for the Cabinet Office, Alex Burghart, expressed enthusiasm about the partnership, highlighting its potential to revolutionize healthcare delivery.

He emphasized the role of AI in boosting efficiency, improving staff satisfaction, and delivering superior service to patients.

Health Minister Lord Markham echoed these sentiments stating, " AI is already transforming the way we deliver healthcare – halving treatment times for stroke patients."

The Charter aligns with the government's broader agenda on AI for the Public Good, as outlined by Deputy Prime Minister Oliver Dowden.

It underscores the commitment to harnessing cutting-edge technology to enhance public services and drive innovation.

Vin Diwakar, Interim National Director of Transformation at NHS England, underscored the NHS's commitment to leveraging AI solutions to improve patient experiences and optimize resource utilization.

"The NHS has already rolled out proven AI solutions, including to improve stroke care, and we see the potential for far wider applications that improve experience for patients and release more time for care," he said.

He emphasized the potential for collaboration with government experts to explore new applications of AI in healthcare delivery.

Importantly, the Charter focuses on non-clinical AI solutions, with a clear emphasis on data privacy and security.

It ensures that patient data remains under the control of the NHS, with i.AI operating within strict data protection guidelines.

Overall, the Collaboration Charter represents a significant milestone in the integration of AI into the NHS ecosystem, promising to unlock new possibilities for improving healthcare delivery and transforming patient outcomes.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less